日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The FGFR1 N546K mutation confers resistance to pemigatinib in MLN-ZMYM2::FGFR1

FGFR1 N546K 突变赋予 MLN-ZMYM2::FGFR1 对 pemigatinib 的耐药性

Shoumariyeh, Khalid; Haug, Stefan; Schwaab, Juliana; Pfeil, Julie K; Stappenbeck, Jannis; Schmitt-Graeff, Annette; Naumann, Nicole; Waltemode, Greta; Zeiser, Robert; Miething, Cornelius; Hofmann, Wolf-Karsten; Meggendorfer, Manja; Diederichs, Sven; Duyster, Justus; Reiter, Andreas

Donor lymphocyte infusions for recurrence of myeloid neoplasms after allogeneic hematopoietic cell transplantation in the era of hypomethylating agents and BCL2 inhibitors

在低甲基化药物和BCL2抑制剂时代,供体淋巴细胞输注治疗异基因造血干细胞移植后髓系肿瘤复发

Jovein, Miriam Mozaffari; Meyer, Thomas; Waterhouse, Miguel; Pfeifer, Dietmar; Duque-Afonso, Jesús; Lübbert, Michael; Maas-Bauer, Kristina; Wäsch, Ralph; Bertz, Hartmut; Duyster, Justus; Zeiser, Robert; Finke, Jürgen; Wehr, Claudia

Primary mediastinal B-cell lymphoma: upfront high-dose chemotherapy with autologous stem cell transplantation results in favorable long-term outcome and may spare radiotherapy

原发性纵隔B细胞淋巴瘤:一线大剂量化疗联合自体干细胞移植可获得良好的长期疗效,并可能避免放疗。

Vollmer, Tino; Strüßmann, Tim; Glatzki, Franziska; Aumann, Konrad; Fritsch, Kristina; Duyster, Justus; Mertelsmann, Roland; Finke, Jürgen; Marks, Reinhard

Oncostatin M induced by STAT5-activating oncogenes promotes disease progression in hematologic malignancies

由STAT5激活癌基因诱导的抑癌素M促进血液系统恶性肿瘤的疾病进展。

Rassner, Michael; Müller, Tony Andreas; Crossley, Kirstyn Anne; Andrieux, Geoffroy; Schaberg, Sabina; Endres, Cornelia; Jakob, Lena; Poggio, Teresa; Köhler, Natalie; Kolter, Julia; Müller-Newen, Gerhard; Schönberger, Katharina; Cabezas-Wallscheid, Nina; Gonzalez-Menendez, Irene; Quintanilla-Martinez, Leticia; Zwick, Melissa; Ashok, Driti; Hartmann, Tanja Nicole; Groß, Olaf; Gorka, Oliver; Follo, Marie; Illert, Anna Lena; Boerries, Melanie; Zeiser, Robert; Duyster, Justus

Efficacy of JAK1/2 inhibition in murine myeloproliferative neoplasms is not mediated by targeting oncogenic signaling

JAK1/2抑制剂在小鼠骨髓增生性肿瘤中的疗效并非通过靶向致癌信号通路介导。

Gorantla, Sivahari Prasad; Rassner, Michael; Crossley, Kirstyn Anne; Müller, Tony Andreas; Poggio, Teresa; Khaja Saleem, Shifa; Kleinfelder, Helen; Gambheer, Sudheer Madan Mohan; Endres, Cornelia; Schaberg, Sabina; Schmidt, Dominik; Prince, Gerin; Gonzalez-Menendez, Irene; Bentrop, Detlef; Trittler, Rainer; Rylova, Svetlana; Pfeifer, Dietmar; Andrieux, Geoffroy; Quintanilla-Martinez, Leticia; Illert, Anna Lena; von Bubnoff, Nikolas; Zeiser, Robert; Duyster, Justus

Dynamic evolution of TCF3-PBX1 leukemias at the single-cell level under chemotherapy pressure

化疗压力下TCF3-PBX1白血病在单细胞水平上的动态演变

Kusterer, Mira; Lahnalampi, Mari; Voutilainen, Minna; Brand, Alexandra; Pennisi, Sandra; Norona, Johana; Gentile, Gaia; Herzog, Heike; Greve, Gabriele; Lübbert, Michael; Sipola, Mikko; Kaartinen, Emma; Sankowski, Roman; Prinz, Marco; Killmer, Saskia; Lago, Marilyn S; Bengsch, Bertram; Cysar, Stepan R; Aumann, Konrad; Werner, Martin; Duyster, Justus; Lohi, Olli; Heinäniemi, Merja; Duque-Afonso, Jesús

Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial

在随机 II 期 DECIDER 试验中,持续接受地西他滨治疗的急性髓系白血病患者出现继发性耐药后,遗传和表观遗传改变的情况

Hund, Inga; Hess, Maria Elena; Andrieux, Geoffroy; Stomper, Julia; Greve, Gabriele; Niemöller, Christoph; Ma, Tobias; Uhl, David; Grishina, Olga; Thol, Felicitas; Heuser, Michael; Bug, Gesine; Crysandt, Martina; Neubauer, Andreas; Duyster, Justus; Döhner, Hartmut; Boerries, Melanie; Lübbert, Michael; Becker, Heiko

The effect of ibrutinib on the myeloid cell compartment in CNS lymphoma

伊布替尼对中枢神经系统淋巴瘤髓系细胞区室的影响

Kuehn, Julia C; Neidert, Nicolas N; Zhang, Junyi; Mutter, Jurik; Alig, Stefan; Klingler, Christian; Hummel, Fabian; Ranganathan, Lavanya; Bleul, Sabine; Beck, Jürgen; Prinz, Marco; Diehn, Maximilian; Alizadeh, Ash; Duyster, Justus; Sankowski, Roman; Heiland, Dieter H; Scherer, Florian

Ruxolitinib mediated paradoxical JAK2 hyperphosphorylation is due to the protection of activation loop tyrosines from phosphatases.

鲁索替尼介导的 JAK2 反常过度磷酸化是由于激活环酪氨酸免受磷酸酶的侵害所致

Gorantla Sivahari P, Oelschläger Lorenz, Prince Gerin, Osius Jasmin, Kolluri Suresh Babu, Maluje Yamil, Fähnrich Anke, Ernst Nancy, Barbosa Gulde Alanis, Ludwig Ralf Joachim, Gemoll Timo, Fliedner Stephanie, Walter Wencke, Haferlach Torsten, Gebauer Niklas, Busch Hauke, Duyster Justus, von Bubnoff Nikolas

Machine learning-based prediction of one-year mortality after alloHCT identifies the impact of pre-transplant immunity and inflammation

基于机器学习的异基因造血干细胞移植后一年死亡率预测揭示了移植前免疫和炎症的影响

Meyer, Thomas; Meyer, Robert; Hackenberg, Maren; Oelke, Daniela; Gengenbach, Laura; Rummelt, Christoph; Wilcken, Hauke; Maas-Bauer, Kristina; Wäsch, Ralph; Duyster, Justus; Bertz, Hartmut; Duque-Afonso, Jesús; Finke, Jürgen; Zeiser, Robert; Wehr, Claudia